Rachel Slayton

Modeling Unit Lead





Appiah GD, Chung A, Bentsi-Enchill AD, Kim S, Crump JA, Mogasale V, Pellegrino R, Slayton RB, Mintz ED. (2020). Typhoid Outbreaks, 1989-2018: Implications for Prevention and Control. The American journal of tropical medicine and hygiene

Octaria R, Chan A, Wolford H, Devasia R, Moon TD, Zhu Y, Slayton RB, Kainer MA. (2020). Web-Based Interactive Tool to Identify Facilities at Risk of Receiving Patients with Multidrug-Resistant Organisms. Emerging infectious diseases, 26(9)

Slayton RB, O'Hagan JJ, Barnes S, Rhea S, Hilscher R, Rubin M, Lofgren E, Singh B, Segre A, Paul P,. (2020). Modeling Infectious Diseases in Healthcare Network (MInD-Healthcare) Framework for Describing and Reporting Multidrug Resistant Organism and Healthcare-Associated Infections Agent-Based Modeling Methods. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

de Man TJB, Yaffee AQ, Zhu W, Batra D, Alyanak E, Rowe LA, McAllister G, Moulton-Meissner H, Boyd S, Flinchum A, Slayton RB, Hancock S, Spalding Walters M, Laufer Halpin A, Rasheed JK, Noble-Wang J, Kallen AJ, Limbago BM. (2020). Multispecies Outbreak of Verona Integron-Encoded Metallo-ß-Lactamase-Producing Multidrugresistant Bacteria Driven by a Promiscuous Incompatibility Group A/C2. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Paul P, Slayton RB, Kallen AJ, Walters MS, Jernigan JA. (2020). Modeling Regional Transmission and Containment of a Healthcare-associated Multidrug-resistant Organism. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70(3)

Han JH, Lapp Z, Bushman F, Lautenbach E, Goldstein EJC, Mattei L, Hofstaedter CE, Kim D, Nachamkin I, Garrigan C, Jain T, Bilker W, Wolford HM, Slayton RB, Wise J, Tolomeo P, Snitkin ES. (2019). Whole-Genome Sequencing To Identify Drivers of Carbapenem-Resistant Klebsiella pneumoniae Transmission within and between Regional Long-Term Acute-Care Hospitals. Antimicrobial agents and chemotherapy, 63(11)

Yi SH, Perkins KM, Kazakova SV, Hatfield KM, Kleinbaum DG, Baggs J, Slayton RB, Jernigan JA. (2019). Surgical site infection risk following cesarean deliveries covered by Medicaid or private insurance. Infection control and hospital epidemiology, 40(6)

Wolford HM, Hatfield KM, Paul P, Yi SH, Slayton RB. (2018). The projected burden of complex surgical site infections following hip and knee arthroplasties in adults in the United States, 2020 through 2030. Infection control and hospital epidemiology, 39(10)

Lee BY, Bartsch SM, Wong KF, McKinnell JA, Slayton RB, Miller LG, Cao C, Kim DS, Kallen AJ, Jernigan JA, Huang SS. (2016). The Potential Trajectory of Carbapenem-Resistant Enterobacteriaceae, an Emerging Threat to Health-Care Facilities, and the Impact of the Centers for Disease Control and Prevention Toolkit. American journal of epidemiology, 183(5)

Bartsch SM, Huang SS, Wong KF, Slayton RB, McKinnell JA, Sahm DF, Kazmierczak K, Mueller LE, Jernigan JA, Lee BY. (2016). Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae. Journal of clinical microbiology, 54(11)

Slayton RB, Scott RD, Baggs J, Lessa FC, McDonald LC, Jernigan JA. (2015). The cost-benefit of federal investment in preventing Clostridium difficile infections through the use of a multifaceted infection control and antimicrobial stewardship program. Infection control and hospital epidemiology, 36(6)

Slayton RB, Murphy JL, Morris J, Faith SH, Oremo J, Odhiambo A, Ayers T, Feinman SJ, Brown AC, Quick RE. (2016). A Cluster Randomized Controlled Evaluation of the Health Impact of a Novel Antimicrobial Hand Towel on the Health of Children Under 2 Years Old in Rural Communities in Nyanza Province, Kenya. The American journal of tropical medicine and hygiene, 94(2)

Slayton RB, Toth D, Lee BY, Tanner W, Bartsch SM, Khader K, Wong K, Brown K, McKinnell JA, Ray W, Miller LG, Rubin M, Kim DS, Adler F, Cao C, Avery L, Stone NT, Kallen A, Samore M, Huang SS, Fridkin S, Jernigan JA. (2015). Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities - United States. MMWR. Morbidity and mortality weekly report, 64(30)

Assi TM, Brown ST, Kone S, Norman BA, Djibo A, Connor DL, Wateska AR, Rajgopal J, Slayton RB, Lee BY. (2013). Removing the regional level from the Niger vaccine supply chain. Vaccine, 31(26)

Slayton RB, Turabelidze G, Bennett SD, Schwensohn CA, Yaffee AQ, Khan F, Butler C, Trees E, Ayers TL, Davis ML, Laufer AS, Gladbach S, Williams I, Gieraltowski LB. (2013). Outbreak of Shiga toxin-producing Escherichia coli (STEC) O157:H7 associated with romaine lettuce consumption, 2011. PLoS One, 8(2)

Slayton RB, Date KA, Mintz ED. (2013). Vaccination for typhoid fever in sub-Saharan Africa. Human vaccines & immunotherapeutics, 9(4)

Assi TM, Rookkapan K, Rajgopal J, Sornsrivichai V, Brown ST, Welling JS, Norman BA, Connor DL, Chen SI, Slayton RB, Laosiritaworn Y, Wateska AR, Wisniewski SR, Lee BY. (2012). How influenza vaccination policy may affect vaccine logistics. Vaccine, 30(30)

Lee BY, Bacon KM, Shah M, Kitchen SB, Connor DL, Slayton RB. (2012). The economic value of a visceral leishmaniasis vaccine in Bihar state, India. The American journal of tropical medicine and hygiene, 86(3)

Lee BY, Assi TM, Rajgopal J, Norman BA, Chen SI, Brown ST, Slayton RB, Kone S, Kenea H, Welling JS, Connor DL, Wateska AR, Jana A, Wiringa AE, Van Panhuis WG, Burke DS. (2012). Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger. American journal of public health, 102(2)